BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28742845)

  • 1. Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.
    Lu L; Zeng J
    PLoS One; 2017; 12(7):e0181532. PubMed ID: 28742845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
    Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
    Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
    Dergham ST; Dugan MC; Kucway R; Du W; Kamarauskiene DS; Vaitkevicius VK; Crissman JD; Sarkar FH
    Int J Pancreatol; 1997 Apr; 21(2):127-43. PubMed ID: 9209954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
    Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
    Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
    Dergham ST; Dugan MC; Arlauskas P; Du W; Vaitkevicius VK; Crissman JD; Sarkar FH
    Int J Pancreatol; 1997 Jun; 21(3):225-34. PubMed ID: 9322121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of genetic alterations in pancreatic cancer: a pooled analysis.
    Blanck HM; Tolbert PE; Hoppin JA
    Environ Mol Mutagen; 1999; 33(2):111-22. PubMed ID: 10217065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
    Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
    Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines.
    Suwa H; Yoshimura T; Yamaguchi N; Kanehira K; Manabe T; Imamura M; Hiai H; Fukumoto M
    Jpn J Cancer Res; 1994 Oct; 85(10):1005-14. PubMed ID: 7961102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis.
    van Heek T; Rader AE; Offerhaus GJ; McCarthy DM; Goggins M; Hruban RH; Wilentz RE
    Am J Clin Pathol; 2002 May; 117(5):755-65. PubMed ID: 12090425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.
    Navas C; Hernández-Porras I; Schuhmacher AJ; Sibilia M; Guerra C; Barbacid M
    Cancer Cell; 2012 Sep; 22(3):318-30. PubMed ID: 22975375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies.
    Fuccio L; Hassan C; Laterza L; Correale L; Pagano N; Bocus P; Fabbri C; Maimone A; Cennamo V; Repici A; Costamagna G; Bazzoli F; Larghi A
    Gastrointest Endosc; 2013 Oct; 78(4):596-608. PubMed ID: 23660563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
    Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
    Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
    Sakai Y; Yanagisawa A; Shimada M; Hidaka E; Seki M; Tada Y; Harada T; Saisho H; Kato Y
    Hum Pathol; 2000 Jul; 31(7):795-803. PubMed ID: 10923915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation.
    Uemura S; Matsubayashi H; Kiyozumi Y; Uesaka K; Yamamoto Y; Sasaki K; Abe M; Urakami K; Kusuhara M; Yamaguchi K
    Fam Cancer; 2018 Apr; 17(2):255-259. PubMed ID: 28755079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and p53 and H-ras mutations in pancreatic ductal adenocarcinoma.
    Ozer E; Ozkal S; Karademir S; Sağol O; Sökmen S; Coker A; Küpelioğlu A; Astarcioğlu I
    Anal Quant Cytol Histol; 1999 Dec; 21(6):473-6. PubMed ID: 10626015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
    Choi H; Kratz J; Pham P; Lee S; Ray R; Kwon YW; Mao JH; Kang HC; Jablons D; Kim IJ
    Int J Oncol; 2012 Jun; 40(6):1900-6. PubMed ID: 22407457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.